Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Corcept Therapeutics reported positive Phase III results for relacorilant in platinum‑resistant ovarian cancer, meeting the overall survival endpoint. The data lifted the stock after a steep decline following a complete response letter that had cut the company's market value by half at year‑end 2025. Relacorilant had previously driven the share price to an all‑time high of $117.33 in March 2025. The rebound suggests renewed investor confidence but the firm still faces challenges from the prior regulatory setback.
Corxel Pharmaceuticals announced a $287 million Series D‑1 financing round aimed at advancing its oral GLP‑1 therapy into late‑stage clinical trials. The capital will enable the company to move beyond its China‑only data and pursue a global development strategy. Existing backers RTW...
A nationwide Danish cohort study examined whether maternal infections during pregnancy raise the risk of suicide in offspring. Using linked health registers, the researchers identified over 1.2 million births and tracked maternal infection diagnoses alongside suicide outcomes up to age...
Astellas CEO Naoki Okamura argues that Japan’s biotech sector is constrained more by the ability to translate scientific discoveries into market‑ready products than by a lack of capital. He outlines Astellas’ strategic focus on cell and gene therapies, a menopause...
The KRAS G12D inhibitor market is heating up as Jiangsu Hengrui, Revolution Medicines and Genfleet announce early‑stage programs, joining Astellas, which first entered the clinic with a KRAS G12D degrader. A new Chinese biotech has released preliminary clinical data, claiming...
Researchers have discovered that glucocorticoid receptor (GR) expression directly influences cerebral lateralization in zebrafish embryos. Using CRISPR‑mediated knock‑down and over‑expression assays, the team quantified asymmetrical gene‑expression patterns and behavioral turning bias. Zebrafish with elevated GR levels showed pronounced left‑right brain...
A recent survey of 1,200 physicians across the United States reveals that 68% view AI chatbots as useful adjuncts in clinical decision‑making, while 22% remain skeptical about their reliability. Doctors cite faster information retrieval and patient education as primary benefits,...
A new multi‑institutional study identifies high PRDM16 expression as a powerful prognostic marker in acute myeloid leukemia (AML). Analysis of over 500 patient transcriptomes shows that elevated PRDM16 correlates with significantly shorter overall survival and remains independent of established risk...
The United States Pharmacopeia (USP) is creating digital reference standards (dRS) and digitally structured compendial methods (dDS) to support digital‑first pharmaceutical workflows. These standards will be incorporated into the USP‑NF, allowing manufacturers to use machine‑readable data instead of physical materials....
Johns Hopkins researchers led by Dwight Bergles uncovered that oligodendrocyte precursor cells (OPCs) continuously differentiate into myelinating oligodendrocytes, a process they term constitutive differentiation. Using cross‑species gene‑expression profiling, protein localization, and live‑mouse time‑lapse microscopy, they identified distinctive “dandelion clock‑like” extracellular...
A recent study demonstrates that pre‑operative transthoracic echocardiography can reliably predict post‑induction hypotension (PIH) in patients over 65. Specific echo metrics, especially markers of diastolic dysfunction, showed strong correlation with intra‑operative blood pressure drops. The predictive model achieved over 80%...
Researchers at the University of California, Riverside have built robotic fins that replicate stingray swimming mechanics, revealing how the animals achieve precise maneuverability. High‑speed video and fluid‑dynamic modeling showed that subtle fin curvature and timing generate lift and thrust efficiently....
Early diagnosis is emerging as the linchpin for effective management of developmental disorders, with recent studies showing that interventions before age three dramatically improve functional outcomes. A multinational cohort of 12,000 infants revealed a 25% boost in adaptive behavior scores...
Researchers at the Institute of Science Tokyo have identified a novel enzyme, MAN PPK2, that universally phosphorylates all four RNA nucleotides into nucleoside triphosphates. The enzyme uses inexpensive polyphosphate as a phosphate donor, enabling a single‑step, low‑cost conversion of monophosphate and...
The U.S. Supreme Court has agreed to hear Hikma Pharmaceuticals’ challenge over the use of “skinny labels,” a practice that allows generic manufacturers to market lower‑cost versions of drugs without copying the original brand’s full label. The case follows years...
In early 2026 pharma giants Eli Lilly, GSK and Pfizer announced multi‑year AI platform agreements with start‑ups Chai Discovery, Noetik, and Boltz. Chai’s de novo antibody design model, Chai‑2, claims double‑digit success rates—over 100‑fold better than prior methods—while Noetik secured a $50 million...
The five largest biotech firms reduced their congressional lobbying expenditures in the fourth quarter of 2025, marking a modest decline from the previous quarter. Collectively, they spent roughly $45 million, down about 4 percent year‑over‑year. The dip reflects tighter corporate budgets and...
University of Wisconsin–Madison researchers have resurrected a 3.2‑billion‑year‑old nitrogenase enzyme and expressed it in modern microbes. Their experiments show the ancient enzyme produces isotopic signatures identical to those of contemporary nitrogenase, confirming the reliability of these signatures as biosignatures in...
So we are the point of questioning polio vaccines. The chair of ACIP: “I think also, as you look at polio, we need to not be afraid to consider that we are in a different time now than we were then....
In 2025 the FDA approved 31 novel small‑molecule drugs, representing 67% of all new drug launches and a slight decline from the previous year. Oncology dominated the portfolio with nine approvals, while 29% were first‑in‑class therapies and 22% received accelerated...
The FDA released new guidance allowing accelerated approval of multiple myeloma therapies based on minimal residual disease (MRD) or complete response endpoints. This shift lets sponsors use single‑arm or randomized trials focused on deep molecular responses, reducing the need for...
Corcept Therapeutics announced that its experimental drug, when combined with standard chemotherapy, cut the risk of death by 35% for patients with a difficult-to‑treat form of ovarian cancer. The reduction was observed in a Phase 2 trial that met its primary...
Roche’s Genentech is increasing its capital outlay for the Holly Springs, North Carolina manufacturing complex to nearly $2 billion, marking a substantial boost to its U.S. production capacity. The additional funds will expand biologics and vaccine output, positioning the site as a...
Bristol Myers Squibb has entered a collaboration with San‑diego biotech Janux Therapeutics to develop a novel tumor‑activated T‑cell engager for solid cancers. The agreement provides Janux with a $50 million upfront cash payment, along with potential milestone and royalty payments. Janux...
The research team introduced ratiometric DNA nanodevices anchored to the cytosolic leaflet of lysosomes, enabling direct measurement of juxta‑lysosomal pH in living cells. They discovered a previously unknown acidic nanolayer up to 21 nm thick on the outer lysosomal membrane, whose...
Researchers at the University of Surrey have created battery‑free nano‑sensors that generate power from tiny human motions. The ultra‑thin borophene‑embedded nanofiber mat, tested with 16 sensors, can monitor sleep patterns and subtle body movements without charging. The self‑powered triboelectric devices...
$CORT +30% pre-market Still room to run? >OS met: HR 0.65 (-35% death risk), mOS 16.0 vs 11.9 mo (+4.1) >PFS (prior): HR 0.70 (-30%) >n=381, safety ≈ control, no biomarker needed What’s next: full dataset at a med meeting; FDA PDUFA Jul 11, 2026...
In this episode, Dr. Liza Lockwood and Cameron J. English dissect the new Dietary Guidelines for Americans, which promote "real food"—full‑fat dairy, fruits, vegetables, and more protein—while still limiting saturated fat to under 10% of calories. They explain how media...
Bristol Myers Squibb has signed a partnership with San Diego‑based Janux Therapeutics, committing up to $850 million in upfront payments and milestone funding to co‑develop a tumor‑activated immunotherapy. The investigational drug targets an undisclosed solid‑tumor antigen and employs a proprietary masking...
The FDA will begin accepting applications for its PreCheck pilot on Feb. 1, 2025, with a one‑month window to submit proposals for new domestic drug‑manufacturing facilities. The program, slated for a June 30 selection deadline, offers early regulatory feedback and a streamlined...
Lexicon Pharmaceuticals received FDA clearance to advance its non‑opioid analgesic pilavapadin into Phase III trials for diabetic peripheral neuropathic pain, following a smooth end‑of‑Phase II meeting. The agency raised no additional study requirements and agreed on a 12‑week, placebo‑controlled design using a...
Pfizer CEO Albert Bourla publicly denounced U.S. Health Secretary Robert F. Kennedy Jr. as "anti‑science" for his vaccine rhetoric, a remark made at the World Economic Forum in Davos. Since Kennedy assumed the HHS role in February 2025, he has questioned...
Pharmapack announced that its flagship pharma packaging and drug‑delivery event will debut in Singapore in November 2026, extending the Europe‑based format to the Asian market. The expansion was revealed during the Pharmapack Europe 2026 awards ceremony held in Paris. The...
Reminder that at $14 $NTLA is *already* trading higher than when the FDA hold was put in place. Novice retailers getting this twisted. There’s no “take backs” on a Hy’s Law case. That is the real problem...
The new chair of the #ACIP was on the Why Should I Trust You? podcast. The interview was ... enlightening. Among other things, Kirk Milhoan seemed to question whether kids still need to be vaccinated against polio & said he...
In a 2026 industry outlook interview, Laine Mello, director of Marketing at Ecolab Life Sciences, said the pharmaceutical sector is under margin pressure and is shifting toward next‑generation therapies such as biologics and advanced modalities. To support these complex products,...
The US withdrawal from #WHO became official today, leaving the world less prepared for dangerous disease outbreaks. “When that will bite us in the ass, it’s impossible to predict. But there is a 100% certainty that it will bite us...
Everyone talks about KNN (K nearest Neighbor) like it’s a simple algorithm. But in practice, especially in single-cell RNA-seq—it’s art, not science. https://t.co/BCreDmtKwZ
Researchers at TU Graz and the University of Graz unveiled Riff‑Diff, a novel AI‑driven platform that builds enzyme scaffolds directly around a chosen active centre. The method combines generative models like RFdiffusion with atomistic refinement, achieving angstrom‑level precision and producing enzymes...
Great progress update on the war on cancer “GBM, colorectal and liver still look very challenging...” See below for detail point down 👇🏼 https://t.co/UTFZSsDVcX
Shanghai‑based Hua Medicine announced a strategic push to broaden its diabetes drug portfolio, aiming to capture a larger slice of the global market. The company is developing an oral GLP‑1 alternative that promises lower dosing and cost advantages over existing...
NICE has issued a draft recommendation approving Roche’s anti‑CD20 antibody Gazyvaro for lupus nephritis patients in England and Wales, making the therapy available to roughly 12,000 people with kidney‑damaging systemic lupus erythematosus. The drug is administered intravenously twice yearly alongside...
A University of Wisconsin‑Madison team sent 1,660 pre‑engineered bacteriophage variants to the International Space Station, letting microgravity and radiation drive co‑evolution with E. coli. In space, bacterial membranes flipped phospholipids outward, prompting surviving phages to acquire hydrophobic receptor‑binding proteins. When...
Recent research highlights ferroptosis—a form of iron‑dependent, lipid‑peroxidation cell death—as a potentially pivotal driver of age‑related muscle loss and weakness. Evidence of ferroptotic signatures appears across cellular, animal, and limited human studies, yet causality remains unproven. The authors propose that...
BioSpace’s Denatured podcast released a post‑JPM episode where senior editor Annalee Armstrong and news editor Dan Samorodnitsky dissect conversations with pharma and biotech executives and investors. Hosted by Jennifer Smith‑Parker, the discussion highlights emerging industry themes and offers forecasts for...
Researchers introduced single‑cell Genotype‑to‑Phenotype sequencing (scG2P) to quantify somatic mosaicism in solid tissues. Applying scG2P to esophageal samples from six older adults, they identified driver mutations in more than half of over 10,000 cells. NOTCH1 mutations were most prevalent, promoting...
Researchers have identified the orphan receptor GPR182 as a potent inhibitor of angiogenesis, acting through modulation of the CXCL12‑CXCR4 signaling pathway. Experimental data show that GPR182 activation curtails endothelial cell migration and reduces VEGF secretion, leading to diminished vessel formation...
A new machine‑learning model has been validated to assess fall risk in seniors with sarcopenia, achieving roughly 85% predictive accuracy. The algorithm integrates gait analysis, muscle‑mass measurements, and balance metrics collected via wearable sensors. Researchers report that the tool can...
Researchers Martinez‑Vallejo, Carrasquel‑Martínez, and Artigues report that HyperSperm, a novel therapeutic cocktail, significantly improves key sperm parameters in human semen samples while maintaining a favorable safety profile. The study, soon to appear in the Journal of Translational Medicine, evaluated multiple...
Cancilico, a Dresden‑based AI diagnostics startup, secured €2.5 million in seed funding led by a consortium that includes High‑Tech Gründerfonds, TGFS, GEDAD GmbH and ROI Verwaltungsgesellschaft. The capital will accelerate the rollout of its AI‑driven software MyeloAID and fast‑track digital biomarker...
